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Abstract: Human toxoplasmosis is a cosmopolitan infection with a wide-ranging prevalence. The prevalence of 
Toxoplasma gondii infection is variable and depends on different eco-epidemiological factors. Both, active 
serological screenings and retrospective analytical methods are usually used for the investigation of toxoplasmosis 
seroprevalence in different populations. We conducted a two-year retrospective database search at a major tertiary 
care hospital to determine the prevalence of toxoplasmosis and its distribution in relation to gender and age among 
Makkah's population. In total, 806 females and 118 males with 33.1±9.1 years, mean age (±SD) were tested for 
anti-T. gondii antibodies in the last two years. Laboratory results revealed 229 seropositive subjects indicating 
24.8% overall toxoplasmosis seroprevalence. Infection rate was significantly higher among male subjects (33.9%) 
than female subjects (23.4%). Seroprevalence increased considerably with age; from 9.7% in children less than 10 
years old to 37.4% and 40.5% among adults between 40 and 49 and over 50 years, respectively. Only two        
anti-T. gondii IgM seropositive cases were recorded along this period, indicating possible active infection. In 
conclusion, overall T. gondii seropositivity rate is relatively low among Makkah's population, but moderate in 
adult males. Further investigations are required to determine the risk factors associated with toxoplasmosis 
transmission in the area. Also, adequate screening for anti-T. gondii specific antibodies are recommended, 
especially for immunocompromised patients and during pregnancy, in order to minimize prospective 
complications. 
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1. Introduction 
 
Toxoplasmosis is a cosmopolitan parasitic infection 
caused by Toxoplasma gondii, obligatory intracellular 
protozoa that can infect almost all warm-blooded 
animals, including humans and many animals of 
economic importance [1]. Individuals become infected 
mostly after ingesting food or water contaminated with 
oocysts that develop in felids intestines and are excreted 
in their feces, or by eating undercooked meat containing 
viable T. gondii tissue cysts. Transmission can occur 
also, but less frequently, by transplacental passage of 
tachyzoites if a primary infection happens during 
pregnancy, after organ transplantation from infected 
donors, transfusion of contaminated blood, and 
inhalation of contaminated dust [2-4]. Nearly a third 
part of the world population has been infected with T. 
gondii parasites, but most of the infections remain 
asymptomatic [5]. Immunocompetent people may 
experiment during active toxoplasmosis, usually after 
one to two weeks of incubation, some mild and 
transient influenza-like illness symptoms including; 
malaise, fever, and lymphadenopathy [6]. Nonetheless, 
severe symptoms may occur during acute infection or 
by reactivation of latent infections in individuals under 
immunosuppressive conditions such as in patients with 
acquired immunodeficiency syndrome and individuals 
on immunosuppressive therapy [7,8]. Toxoplasmosis 
may lead to serious individual health consequences 
because of the major clinical abnormalities and 
problems that affect vulnerable patients like blindness, 
hearing loss, and intellectual disabilities [9,10]. 
Consequently, toxoplasmosis represents an important 
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public health impact in terms of socioeconomic issues 
and costs of caring for patients [11,12]. 
Diagnosis of toxoplasmosis is made according to 
the subject immune background and on the observed 
signs and symptoms. But, because the infection is 
generally asymptomatic, screening policies rely on 
indirect serological methods for detection of anti-T. 
gondii antibodies of different isotypes [13-15]. 
Seroprevalence investigation of anti-T. gondii IgG and 
IgM antibodies offer an efficient method for estimating 
the incidence and prevalence of the infection within a 
studied group in particular but also reflects the spread 
of the infection among the general society [16]. 
This study was conducted to evaluate and update  
T. gondii seroprevalence among Makkah's population. 
For this purpose, laboratory data of individuals who 
attended a major tertiary care hospital and were 
examined for toxoplasmosis during the last two years 
were collected and statistically analyzed. 
 
2.  Subjects and Methods 
 
This is a retrospective cross-sectional data analysis 
of laboratory records at a major tertiary health hospital 
in Makkah province, Saudi Arabia. The study targeted 
all individuals who attended inpatient and outpatient 
clinics of the hospital during the last two years and were 
examined for anti-T. gondii total antibodies and/or   
anti-T. gondii specific IgM in order to estimate the rate 
of T. gondii infection among Makkah population and 
the proportion of acute cases.  
Records of serology results were collected in 
parallel with age and gender of all examined subjects. 
Relative seroprevalence rates were calculated by gender 
groups and compared. Subjects were divided into 10 
year age groups to assess the progression of T. gondii 
infection rate with age. Statistical analysis was 
performed using Microsoft Excel software on a 
personal computer. 
The study protocol was approved by our 
institutional review board. We declare that we have no 
financial or personal relationship which may have 
inappropriately influenced us in writing this paper. 
 
3.  Results 
 
Out of 924 persons who visited the tertiary health 
hospital during the last two years and were examined 
for anti-T. gondii total antibodies, 229 (24.8%) were 
found seropositive and 695 negatives, indicating a non-
previous exposure to the parasite. Only two cases were 
found seropositive for anti-T. gondii IgM specific 
antibodies out of 643 individuals examined for IgM, 
showing a 0.3% prevalence of possible recent or active 
toxoplasmosis (Table 1). In total, 806 females and 118 
males with 33.1±9.1 average age (±SD) were tested. 
The average age among male individuals was 35.2 
years old (±16.4 SD), while in the female group the 
average age was 32.7 years (±7.2 SD). Toxoplasmosis 
seroprevalence analysis by gender showed statistically 
significant sex difference (P<0.01); calculated 
seroprevalence was 33.9% among male subjects and 
23.4% among female subjects (Table 2). Infection rate 
increased considerably with age; from 9.7% in children 
less than 10 years old to 16.6%, 17.1%, 24.3%, and 
37.4% progressively among the subsequent 10 year age 
groups, to 40.5% among persons over 50 years (Fig. 1). 
 
Table 1. Seroprevalence of anti-T. gondii total antibodies and anti-
T. gondii specific IgM at a tertiary health care center in Makkah, 
Saudi Arabia. 
 
Serological test Subjects Positives Relative Seroprevalence 
Total antibodies anti-T. gondii 924 229 24.8% 
IgM anti-T. gondii 643 2 0.3% 
 
Table 2. Relationship between gender and Toxoplasma gondii 
seroprevalence at a tertiary health care center in Makkah, Saudi 
Arabia. 
 
Gender Examined subjects 
Mean age 
±SD 
Seropositive 
subjects Seroprevalence 
Females 806 32.7 ± 7.2 189 23.4% 
Males 118 35.2 ± 16.4 40 33.9% 
overall 924 33.1 ± 9.1 229 24.8% 
 
 
 
Fig. 1. Toxoplasmosis seroprevalence according to 10-year age 
groups at a tertiary health care center in Makkah, Saudi Arabia. 
 
4.  Discussion 
 
Toxoplasmosis is a widespread infection with 
significant public health impact in terms of consequent 
socioeconomic problems and elevated costs of caring 
for patients who suffer serious clinical conditions, 
generally of ocular and neurological nature [12,17,18]. 
Nearly a third part of the world population has been 
infected with T. gondii parasites and most of them 
remain asymptomatic [5]. Toxoplasmosis prevalence 
varies considerably among different regions and 
populations throughout the world [15]. This 
discrepancy has been linked to different kind of factors: 
immunological, educational, occupational, 
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socioeconomic, cultural, environmental, and others 
[19,20]. 
The current study, carried out in Makkah city in 
Saudi Arabia, western region, revealed an overall 
toxoplasmosis seroprevalence of 24.8%. Toxoplasmosis 
infection rates less than 30% are considered as 
relatively low [15]. Similarly, low seroprevalence rates 
have been observed in other countries like in; Japan 
10.3%, USA 13.2%, China 16.8%, UK 17.3%, and 
Thailand 28.3% [21-25]. By other hand, moderate (30-
50%) and high (>50%) infection rates were reported in 
many countries; 30.1% in Turkey, 45.8% in Colombia, 
55% in Germany, 68.8% in Brazil, and 92.5% in Ghana 
[26-30]. In Saudi Arabia, different regional 
seroprevalence rates of toxoplasmosis were lately 
reported; 24.1% in Jazan, 28.5% in Dhahran, 38% in 
Riyadh, 38.8 % in southwestern region, and 51.4% in 
Al-Ahsa [31-35]. It has been reported that 
toxoplasmosis seroprevalence is influenced by 
socioeconomic and educational status of each 
population, but also, it is directly associated with the 
level of exposure to T. gondii parasites which are higher 
in rural areas and small villages than urban areas in 
Saudi Arabia [36]. 
Toxoplasmosis seroprevalence was found higher in 
men’s group compared to women, 33.9% versus 23.4%, 
respectively, with a statistically significant gender 
difference (P<0.01). It is agreed that the occurrence of 
toxoplasmosis is relatively influenced by the gender of 
the hosts; more likely due to gender-associated 
differences consisting of lower immune resistance to 
parasites in men with a higher exposure risk due to 
occupational activities [37,38]. In addition, we should 
mention that the average age of male subjects were 
higher than female group in this study, 35.2 versus 32.7 
years. The infection rate increased significantly as the 
age of hosts increased, from 9.7% in children less than 
10 years old to 37.4% and 40.5% among 40 to 49 age 
range and persons above 50 years, respectively. Thus 
the age was a determinant factor in the distribution 
toxoplasmosis seroprevalence among the studied 
population. It has been reported as an evidentiary fact 
that T. gondii seroprevalence increases with age in 
almost all established communities [39-41]. 
Only two cases were found seropositive for       
anti-T. gondii IgM specific antibodies during the period 
of the study. Serological examination for anti-T. gondii 
IgM is usually the approach for primary active 
toxoplasmosis screening but since anti-T. gondii IgM 
antibodies may persist in peripheral blood for long 
periods of development, their detection is not 
completely confirmative of recent or acute infection 
[42,43]. As well, natural antibodies of IgM class may 
occasionally be present in non-infected persons and 
react with the parasite antigens in serological tests [44, 
45]. Seropositive anti-T. gondii IgM cases necessitate 
more investigations to confirm or discard acute form of 
toxoplasmosis. 
 
5.  Conclusion 
 
A relatively low toxoplasmosis overall 
seroprevalence (24.8%) was found among individuals 
who visited a tertiary care hospital at the Makkah city 
during the last two years. Seropositivity rate was higher 
in men than women, indicating a higher infection risk 
for male population. Further investigations are required 
to determine the risk factors associated with 
toxoplasmosis transmission in the area. 
 
References 
 
[1]. Montoya, J.G., Boothroyd, J.C. & Kovacs, J.A. 
(2010). Toxoplasma gondii. In: Mandell, G.L., 
Bennett, J.E., Dolin, R., editors. Principles and 
Practice of Infectious Diseases. Seventh edition. 
Philadelphia, USA: Churchill Livingstone, pp. 
3485–3526. 
[2]. Teutsch, S.M., Juranek, D.D., Sulzer, A., Dubey, 
J.P. & Sikes, R.K. (1979). Epidemic 
toxoplasmosis associated with infected cats. N. 
Engl. J. Med., 300(13): 695-699. 
[3]. Montoya, J.G. & Liesenfeld, O. (2004). 
Toxoplasmosis. Lancet, 363: 1965-1976. 
[4]. Dubey, J.P. & Jones, J.L. (2008). Toxoplasma 
gondii infection in humans and animals in the 
United States. Int. J. Parasitol., 38: 1257-1278. 
doi: 10.1016/j.ijpara.2008.03.007. 
[5]. Tenter, A.M., Heckeroth, A.R. & Weiss, L.M. 
(2000). Toxoplasma gondii: from animals to 
humans. Int. J. Parasitol., 30(12-13): 1217-1258. 
[6]. Weiss, L.M. & Dubey, J.P. (2009). 
Toxoplasmosis: A history of clinical observations. 
Int. J. Parasitol., 39: 895-901. doi: 
10.1016/j.ijpara.2009.02.004. 
[7]. Hill, D.E., Chirukandoth, S. & Dubey, J.P. (2005). 
Biology and epidemiology of Toxoplasma gondii 
in man and animals. Anim. Health Res. Rev., 6(1): 
41-61. 
[8]. Hoffmann, C. (2005). Opportunistic infections. 
In HIV Medicine. Edited by C. Hoffmann, J.K. 
Rockstroh & B.S. Kamps. Paris: Flying Publisher. 
[9]. Vutova, K., Peicheva, Z., Popova, A., Markova, 
V., Mincheva, N. & Todorov, T. (2002). 
Congenital toxoplasmosis: eye manifestations in 
infants and children. Ann. Trop. Paediatr., 22(3): 
213-218. 
[10]. Torrey, E.F. & Yolken, R.H. (2003). Toxoplasma 
gondii and Schizophrenia. Emerg. Infect. Dis., 
9(11): 1375-1380. 
https://dx.doi.org/10.3201/eid0911.030143. 
[11]. Roberts, T., Murrell, K.D. & Marks, S. (1994). 
Economic losses caused by foodborne parasitic 
diseases. Parasitol. Today, 10(11): 419-23. 
[12]. Stillwaggon, E., Carrier, C.S., Sautter, M. & 
McLeod, R. (2011). Maternal serologic screening 
to prevent congenital toxoplasmosis: a decision-
Toxoplasma gondii seroprevalence in Makkah                        Zaglool et al 
 
J. Adv. Lab. Res. Biol.  39 
analytic economic model. PLoS Negl. Trop. Dis., 
5(9):e1333. doi: 10.1371/journal.pntd.0001333. 
[13]. Bobić, B., Sibalić, D. & Djurković-Djaković, O. 
(1991). High levels of IgM antibodies specific for 
Toxoplasma gondii in pregnancy 12 years after 
primary toxoplasma infection. Gynecol. Obstet. 
Invest., 31(3): 182-184. 
[14]. Joynson, D.H.M. & Guy, E.C. (2001). Laboratory 
diagnosis of toxoplasma infection. In: Joynson, 
D.H.M., Wreghitt, T.G., editors. Toxoplasmosis: a 
Comprehensive Clinical Guide. Cambridge, UK: 
Cambridge University Press. pp. 296–318. 
[15]. Robert-Gangneux, F. & Dardé, M.L. (2012). 
Epidemiology of and diagnostic strategies for 
toxoplasmosis. Clin. Microbiol. Rev., 25(2): 264-
296. doi: 10.1128/CMR.05013-11. 
[16]. Frenkel, J.K. (1990). Toxoplasmosis in human 
beings. J. Am. Vet. Med. Assoc., 196: 240-248.  
[17]. Lopez, A., Dietz, V.J., Wilson, M., Navin, T.R. & 
Jones, J.L. (2000). Preventing congenital 
toxoplasmosis. MMWR Recomm. Rep., 49(RR-2): 
59-68. 
[18]. Jones, J.L. & Holland, G.N. (2010). Annual 
burden of ocular toxoplasmosis in the United 
States. Am. J. Trop. Med. Hyg., 82: 464-465. 
[19]. Jones, J.L., Kruszon-Moran, D., Wilson, M., 
McQuillan, G., Navin, T. & McAuley, J.B. 
(2001). Toxoplasma gondii infection in the United 
States: seroprevalence and risk factors. Am. J. 
Epidemiol., 154: 357-365. 
[20]. Furtado, J.M., Smith, J.R., Belfort, R., Gattey, D. 
& Winthrop, K.L. (2011). Toxoplasmosis: a 
global threat. J. Glob. Infect. Dis., 3: 281-284. 
[21]. Sakikawa, M., Noda, S., Hanaoka, M., Nakayama, 
H., Hojo, S., Kakinoki, S., Nakata, M., Yasuda, 
T., Ikenoue, T. & Kojima, T. (2012). Anti-
Toxoplasma antibody prevalence, primary 
infection rate, and risk factors in a study of 
toxoplasmosis in 4,466 pregnant women in Japan. 
Clin. Vaccine Immunol., 19(3): 365-367. doi: 
10.1128/CVI.05486-11. 
[22]. Jones, J.L., Kruszon-Moran, D., Rivera, H.N., 
Price, C. & Wilkins, P.P. (2014). Toxoplasma 
gondii seroprevalence in the United States 2009-
2010 and comparison with the past two 
decades. Am. J. Trop. Med. Hyg., 90(6): 1135-
1139. doi: 10.4269/ajtmh.14-0013. 
[23]. Cong, W., Dong, X.Y., Meng, Q.F., Zhou, N., 
Wang, X.Y., Huang, S.Y., Zhu, X.Q. & Qian, 
A.D. (2015). Toxoplasma gondii Infection in 
Pregnant Women: A Seroprevalence and Case-
Control Study in Eastern China. BioMed Res. Int., 
Article ID 170278. Doi: 10.1155/2015/170278.  
[24]. Flatt, A. & Shetty, N. (2013). Seroprevalence and 
risk factors for toxoplasmosis among antenatal 
women in London: a re-examination of risk in an 
ethnically diverse population. Eur. J. Public 
Health, 23(4): 648-652. doi: 
10.1093/eurpub/cks075. 
[25]. Nissapatorn, V., Suwanrath, C., Sawangjaroen, 
N., Ling, L.Y. & Chandeying, V. (2011). 
Toxoplasmosis-serological evidence and 
associated risk factors among pregnant women in 
southern Thailand. Am. J. Trop. Med. Hyg., 85(2): 
243-247. doi: 10.4269/ajtmh.2011.10-0633. 
[26]. Ertug, S., Okyay, P., Turkmen, M. & Yuksel, H. 
(2005). Seroprevalence and risk factors for 
Toxoplasma infection among pregnant women in 
Aydin province, Turkey. BMC Public Health, 5: 
66. doi:10.1186/1471-2458-5-66 
[27]. Rosso, F., Les, J.T., Agudelo, A., Villalobos, C., 
Chaves, J.A., Tunubala, G.A., Messa, A., 
Remington, J.S. & Montoya, J.G. (2008). 
Prevalence of infection with Toxoplasma gondii 
among pregnant women in Cali, Colombia, South 
America. Am. J. Trop. Med. Hyg., 78: 504-508. 
[28]. Wilking, H., Thamm, M., Stark, K., Aebischer, T. 
& Seeber, F. (2016). Prevalence, incidence 
estimations, and risk factors of Toxoplasma gondii 
infection in Germany: a representative, cross-
sectional, serological study. Sci. Rep., 6: 22551. 
doi: 10.1038/srep22551. 
[29]. Sroka, S., Bartelheimer, N., Winter, A., 
Heukelbach, J., Ariza, L., Ribeiro, H., Oliveira, 
F.A., Queiroz, A.J., Alencar, C. Jr., Liesenfeld, O. 
(2010). Prevalence and risk factors of 
toxoplasmosis among pregnant women in 
Fortaleza, Northeastern Brazil. Am. J. Trop. Med. 
Hyg., 83(3): 528-533. doi: 
10.4269/ajtmh.2010.10-0082. 
[30]. Ayi, I., Edu, S.A., Apea-Kubi, K.A., Boamah, D., 
Bosompem, K.M. & Edoh, D. (2009). Sero-
epidemiology of toxoplasmosis amongst pregnant 
women in the greater Accra region of 
Ghana. Ghana Med. J., 43(3): 107-114. 
[31]. Aqeely, H., El-Gayar, E.K., Perveen Khan, D., 
Najmi, A., Alvi, A., Bani, I., Mahfouz, M.S., 
Abdalla, S.E., & Elhassan, I.M. (2014). 
Seroepidemiology of Toxoplasma gondii amongst 
Pregnant Women in Jazan Province, Saudi Arabia. 
J. Trop. Med., vol. 2014: 913950. doi: 
10.1155/2014/913950. 
[32]. Elsafi, S.H., Al-Mutairi, W.F., Al-Jubran, K.M., 
Abu Hassan, M.M. & Al Zahrani, E.M. (2015). 
Toxoplasmosis seroprevalence in relation to 
knowledge and practice among pregnant women 
in Dhahran, Saudi Arabia. Pathog. Glob. Health, 
109(8): 377-382. doi: 
10.1080/20477724.2015.1103502. 
[33]. Almogren, A. (2011). Antenatal screening for 
Toxoplasma gondii infection at a tertiary care 
hospital in Riyadh, Saudi Arabia. Ann. Saudi 
Med., 31(6):569-572. doi: 10.4103/0256-
4947.87090.  
[34]. Almushait, M.A., Dajem, S.M., Elsherbiny, N.M., 
Eskandar, M.A., Al Azraqi, T.A. & Makhlouf, 
L.M. (2014). Seroprevalence and risk factors of 
Toxoplasma gondii infection among pregnant 
Toxoplasma gondii seroprevalence in Makkah                        Zaglool et al 
 
J. Adv. Lab. Res. Biol.  40 
women in south western, Saudi Arabia. J. Parasit. 
Dis., 38(1): 4-10. doi: 10.1007/s12639-012-0195-
z. 
[35]. Al-Mohammad, H.I., Amin, T.T., Balaha, M.H. & 
Al-Moghannum, M.S. (2010). Toxoplasmosis 
among the pregnant women attending a Saudi 
maternity hospital: seroprevalence and possible 
risk factors. Ann. Trop. Med. Parasitol., 
104(6):493-504. doi: 
10.1179/136485910X12786389891443. 
[36]. Al-Qurashi, A.R., Ghandour, A.M., Obeid, O.E., 
Al-Mulhim, A. & Makki, S.M. (2001). 
Seroepidemiological study of Toxoplasma gondii 
infection in the human population in the Eastern 
Region. Saudi Med. J., 22: 13-18.  
[37]. Kim, Y.H., Lee, J., Ahn, S., Kim, T.S., Hong, S.J., 
Chong, C.K., Ahn, H.J. & Nam, H.W. (2017). 
High Seroprevalence of Toxoplasmosis Detected 
by RDT among the Residents of Seokmo-do 
(Island) in Ganghwa-Gun, Incheon City, Korea. 
Korean J. Parasitol., 55(1): 9-13. doi: 
10.3347/kjp.2017.55.1.9. 
[38]. Alvarado-Esquivel, C., Rascón-Careaga, A., 
Hernández-Tinoco, J., Corella-Madueño, M.A., 
Sánchez-Anguiano, L.F., Aldana-Madrid, M.L., 
Velasquez-Vega, E., Quizán-Plata, T., Navarro-
Henze, J.L., Badell-Luzardo, J.A., Gastélum-
Cano, J.M. & Liesenfeld, O. (2016). 
Seroprevalence and Associated Risk Factors for 
Toxoplasma gondii Infection in Healthy Blood 
Donors: A Cross-Sectional Study in Sonora, 
Mexico. Biomed Res. Int., 2016: 9597276. doi: 
10.1155/2016/9597276. 
[39]. Cavalcante, G.T., Aguilar, D.M., Camargo, L.M., 
Labruna, M.B., de Andrade, H.F., Meireles, L.R., 
Dubey, J.P., Thulliez, P., Dias, R.A. & Gennari, 
S.M. (2006). Seroprevalence of Toxoplasma 
gondii antibodies in humans from rural Western 
Amazon, Brazil. J. Parasitol., 92(3): 647-649. 
[40]. Gargaté, M.J., Ferreira, I., Vilares, A., Martins, S., 
Cardoso, C., Silva, S., Nunes, B. & Gomes, J.P. 
(2016). Toxoplasma gondii seroprevalence in the 
Portuguese population: comparison of three cross-
sectional studies spanning three decades. BMJ 
Open, 6(10): e011648. doi: 10.1136/bmjopen-
2016-011648. 
[41]. Mahdy, M.A., Alareqi, L.M., Abdul-Ghani, R., 
Al-Eryani, S.M., Al-Mikhlafy, A.A., Al-Mekhlafi, 
A.M., Alkarshy, F. & Mahmud, R. (2017). A 
community-based survey of Toxoplasma gondii 
infection among pregnant women in rural areas of 
Taiz governorate, Yemen: the risk of waterborne 
transmission. Infect. Dis. Poverty., 6(1): 26. doi: 
10.1186/s40249-017-0243-0. 
[42]. Liesenfeld, O., Press, C., Montoya, J.G., Gill, R., 
Isaac-Renton, J.L., Hedman, K. & Remington, J.S. 
(1997). False-positive results in immunoglobulin 
M (IgM) toxoplasma antibody tests and 
importance of confirmatory testing: the Platelia 
Toxo IgM test. J. Clin. Microbiol., 35: 174-178. 
[43]. Dhakal, R., Gajurel, K., Pomares, C., Talucod, J., 
Press, C.J. & Montoya, J.G. (2015). Significance 
of a Positive Toxoplasma Immunoglobulin M Test 
Result in the United States. J. Clin. Microbiol., 
53(11): 3601-3605. doi: 10.1128/JCM.01663-15. 
[44]. Konishi, E. (1987). A pregnant woman with a 
high level of naturally occurring immunoglobulin 
M antibodies to Toxoplasma gondii. Am. J. 
Obstet. Gynecol., 157: 832-833. 
[45]. Sensini, A. (2006). Toxoplasma gondii infection 
in pregnancy: opportunities and pitfalls of 
serological diagnosis. Clin. Microbiol. Infect., 12: 
504-512. 
 
